Provided by Tiger Trade Technology Pte. Ltd.

PMGC Holdings

6.66
+0.56009.18%
Post-market: 6.62-0.0400-0.60%19:59 EDT
Volume:203.82K
Turnover:1.32M
Market Cap:5.39M
PE:0.00
High:7.29
Open:6.60
Low:5.98
Close:6.10
52wk High:3,091.20
52wk Low:5.40
Shares:809.58K
Float Shares:764.19K
Volume Ratio:2.71
T/O Rate:26.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1,801.7300
EPS(LYR):-3,806.9050
ROE:-105.22%
ROA:-32.97%
PB:0.32
PE(LYR):0.00

Loading ...

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:47 PM

Reuters
·
Apr 02

PMGC Holdings Inc trading resumes

TIPRANKS
·
Apr 01

Wall Street Set to Open Higher as Trump Says US Will Consider Ceasefire if Hormuz Strait Opened

MT Newswires Live
·
Apr 01

Top Premarket Gainers

MT Newswires Live
·
Apr 01

PMGC Holdings Is Trending Overnight: Here's Why ELAB Stock Shot Up 28% Overnight

Benzinga_recent_news
·
Apr 01

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:25 PM

Reuters
·
Apr 01

Aga Precision Systems - Long-Term Agreement Includes Initial Five-Year Term With Annual Renewals

THOMSON REUTERS
·
Mar 31

AGA Precision Systems Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products

GlobeNewswire
·
Mar 31

Why Is PMGC Holdings Stock (ELAB) Up Today?

TIPRANKS
·
Mar 30

PMGC net loss from continuing operations widens to USD 7.78 million in FY25

Reuters
·
Mar 30

Pmgc Holdings Inc. [Nasdaq: Elab] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase From 2024

THOMSON REUTERS
·
Mar 30

Press Release: PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024

Dow Jones
·
Mar 30

Why PMGC Holdings Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket

Benzinga
·
Mar 30

Stocks to Watch: PMGC, Cue Biopharma

Dow Jones
·
Mar 28

PMGC Shares Soar After Subsidiary Amends License Agreement

Dow Jones
·
Mar 28

NorthStrive Biosciences signs third amendment to MOA Life Plus license agreement; EL-32 and EL-22 clinical development milestones shift

Reuters
·
Mar 28

Northstrive Biosciences Signs Licensing Agreement Amendment With Moa Life Plus [Kosdaq: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination With Glp-1 Treatments

THOMSON REUTERS
·
Mar 28

PMGC Holdings subsidiary Northstrive Biosciences amends MOA Life Plus license agreement; payment to MOA due within 30 days of March 24, 2026 effective date

Reuters
·
Mar 27

PMGC Holdings Subsidiary Gains ITAR Defense Compliance Status

TIPRANKS
·
Mar 24

PMGC subsidiary completes ITAR registration

TIPRANKS
·
Mar 24